<DOC>
	<DOCNO>NCT00348374</DOCNO>
	<brief_summary>The current trial examine efficacy safety Exubera administer mealtime insulin compare lispro , add exist regimen basal insulin glargine + = Oral Agents ( OAs ) . Dose titration provide allow large proportion subject reach target glycosylated hemoglobin ( A1C ) level .</brief_summary>
	<brief_title>Exubera vs Lispro Lantus-based Regimen Improved Glycemic Control Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Adults type 2 diabetes use LantusÂ® ( insulin glargine ) basal insulin , glycemic goal . lung disease current smoking discontinue smoke within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>type two diabetes , insulin , HbA1c</keyword>
</DOC>